Impact of body composition parameters on clinical outcomes in patients with metastatic castration-resistant prostate cancer treated with docetaxel

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalJournal of Clinical Oncology
DOIs
Publication statusPublished - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Medicine
  • Docetaxel
  • Prostate cancer
  • Sarcopenia
  • Internal medicine
  • Neutropenia
  • Cancer
  • Overweight
  • Chemotherapy
  • Sarcopenic obesity
  • Toxicity
  • Oncology
  • Urology
  • Surgery
  • Body mass index

Cite this